Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose...

  • Main
  • 2020 / 08
  • Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose...
Diabetes, Obesity and Metabolism 2020 / 08

Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents ‐Post‐hoc Analyses from DECLARE‐TIMI 58

Cahn, Avivit, Wiviott, Stephen D., Mosenzon, Ofri, Murphy, Sabina A., Goodrich, Erica L., Yanuv, Ilan, Rozenberg, Aliza, Wilding, John P.H., Leiter, Lawrence A., Bhatt, Deepak L., McGuire, Darren K.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.14179
Date:
August, 2020
File:
PDF, 1.39 MB
2020
Conversion to is in progress
Conversion to is failed